These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34449129)

  • 41. Solid-State Stability Issues of Drugs in Transdermal Patch Formulations.
    Sharma PK; Panda A; Pradhan A; Zhang J; Thakkar R; Whang CH; Repka MA; Murthy SN
    AAPS PharmSciTech; 2018 Jan; 19(1):27-35. PubMed ID: 28895101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potential and problems of developing transdermal patches for veterinary applications.
    Riviere JE; Papich MG
    Adv Drug Deliv Rev; 2001 Sep; 50(3):175-203. PubMed ID: 11500227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of gliclazide ionic liquid and the transdermal patches: An effective and noninvasive sustained release formulation to achieve hypoglycemic effects.
    Zhou B; Liu S; Yin H; Qi M; Hong M; Ren GB
    Eur J Pharm Sci; 2021 Sep; 164():105915. PubMed ID: 34146681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effective use of transdermal drug delivery in children.
    Delgado-Charro MB; Guy RH
    Adv Drug Deliv Rev; 2014 Jun; 73():63-82. PubMed ID: 24333231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patches.
    Ahmed OA; Afouna MI; El-Say KM; Abdel-Naim AB; Khedr A; Banjar ZM
    Expert Opin Drug Deliv; 2014 Jul; 11(7):1005-13. PubMed ID: 24702435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of novel pH-sensitive nanoparticle-based transdermal patch for management of rheumatoid arthritis.
    Khan D; Qindeel M; Ahmed N; Khan AU; Khan S; Rehman AU
    Nanomedicine (Lond); 2020 Mar; 15(6):603-624. PubMed ID: 32098563
    [No Abstract]   [Full Text] [Related]  

  • 47. Device-assisted transdermal drug delivery.
    Lee H; Song C; Baik S; Kim D; Hyeon T; Kim DH
    Adv Drug Deliv Rev; 2018 Mar; 127():35-45. PubMed ID: 28867296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transport efficiency in transdermal drug delivery: What is the role of fluid microstructure?
    Liuzzi R; Carciati A; Guido S; Caserta S
    Colloids Surf B Biointerfaces; 2016 Mar; 139():294-305. PubMed ID: 26799505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Permeation enhancers in transdermal drug delivery: benefits and limitations.
    Kováčik A; Kopečná M; Vávrová K
    Expert Opin Drug Deliv; 2020 Feb; 17(2):145-155. PubMed ID: 31910342
    [No Abstract]   [Full Text] [Related]  

  • 50. Transdermal skin patch based on reduced graphene oxide: A new approach for photothermal triggered permeation of ondansetron across porcine skin.
    Teodorescu F; Quéniat G; Foulon C; Lecoeur M; Barras A; Boulahneche S; Medjram MS; Hubert T; Abderrahmani A; Boukherroub R; Szunerits S
    J Control Release; 2017 Jan; 245():137-146. PubMed ID: 27914995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultrasound and transdermal drug delivery.
    Lavon I; Kost J
    Drug Discov Today; 2004 Aug; 9(15):670-6. PubMed ID: 15279850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent progress in transdermal sonophoresis.
    Ita K
    Pharm Dev Technol; 2017 Jun; 22(4):458-466. PubMed ID: 26608060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transdermal patches: history, development and pharmacology.
    Pastore MN; Kalia YN; Horstmann M; Roberts MS
    Br J Pharmacol; 2015 May; 172(9):2179-209. PubMed ID: 25560046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Taro corms mucilage/HPMC based transdermal patch: an efficient device for delivery of diltiazem hydrochloride.
    Sarkar G; Saha NR; Roy I; Bhattacharyya A; Bose M; Mishra R; Rana D; Bhattacharjee D; Chattopadhyay D
    Int J Biol Macromol; 2014 May; 66():158-65. PubMed ID: 24556117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ask the experts: transdermal drug delivery.
    Ther Deliv; 2013 Oct; 4(10):1235-8. PubMed ID: 24116908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug crystallization - implications for topical and transdermal delivery.
    Hadgraft J; Lane ME
    Expert Opin Drug Deliv; 2016 Jun; 13(6):817-30. PubMed ID: 26766744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parafilm® M and Strat-M® as skin simulants in in vitro permeation of dissolving microarray patches loaded with proteins.
    Anjani QK; Nainggolan ADC; Li H; Miatmoko A; Larrañeta E; Donnelly RF
    Int J Pharm; 2024 Apr; 655():124071. PubMed ID: 38554738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress in the use of microemulsions for transdermal and dermal drug delivery.
    Ita K
    Pharm Dev Technol; 2017 Jun; 22(4):467-475. PubMed ID: 26931453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strategies for transdermal drug delivery against bone disorders: A preclinical and clinical update.
    Sharma G; Alle M; Chakraborty C; Kim JC
    J Control Release; 2021 Aug; 336():375-395. PubMed ID: 34175368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioresponsive transcutaneous patches.
    Yu J; Zhang Y; Kahkoska AR; Gu Z
    Curr Opin Biotechnol; 2017 Dec; 48():28-32. PubMed ID: 28292673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.